• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Mark W. Kieran, MD, PhD

Publications

  • Kieran MW.Targeting BRAF in Pediatric Brain Tumors.Am Soc Clin Oncol Educ Book. 2014;34:e436-40.
    24857135
  • Gordon LB, Massaro J, D'Agostino RB, Campbell SE, Brazier J, Brown WT, Kleinman ME, Kieran MW.Impact of Farnesylation Inhibitors on Survival in Hutchinson-Gilford Progeria Syndrome.Circulation. 2014 May 2.
    24795390
  • Robison NJ, Kieran MW.Diffuse intrinsic pontine glioma: a reassessment.J. Neurooncol. 2014 May 3.
    24792486
  • Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO, Bechet D, Faury D, De Jay N, Ramkissoon LA, Corcoran A, Jones DT, Sturm D, Johann P, Tomita T, Goldman S, Nagib M, Bendel A, Goumnerova L, Bowers DC, Leonard JR, Rubin JB, Alden T, Browd S, Geyer JR, Leary S, Jallo G, Cohen K, Gupta N, Prados MD, Carret AS, Ellezam B, Crevier L, Klekner A, Bognar L, Hauser P, Garami M, Myseros J, Dong Z, Siegel PM, Malkin H, Ligon AH, Albrecht S, Pfister SM, Ligon KL, Majewski J, Jabado N, Kieran MW.Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.Nat Genet. 2014 May;46(5):462-6.
    24705250
  • Widemann BC, Babovic-Vuksanovic D, Dombi E, Wolters PL, Goldman S, Martin S, Goodwin A, Goodspeed W, Kieran MW, Cohen B, Blaney SM, King A, Solomon J, Patronas N, Balis FM, Fox E, Steinberg SM, Packer RJ.Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.Pediatr Blood Cancer. 2014 Apr 22.
    24753394
  • Bergthold G, Bandopadhayay P, Bi WL, Ramkissoon L, Stiles C, Segal RA, Beroukhim R, Ligon KL, Grill J, Kieran MW.Pediatric low-grade gliomas: How modern biology reshapes the clinical field.Biochim Biophys Acta. 2014 Apr;1845(2):294-307.
    24589977
  • Widemann BC, Dombi E, Gillespie A, Wolters PL, Belasco J, Goldman S, Korf BR, Solomon J, Martin S, Salzer W, Fox E, Patronas N, Kieran MW, Perentesis JP, Reddy A, Wright JJ, Kim A, Steinberg SM, Balis FM.Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.Neuro Oncology. 2014 May;16(5):707-18.
    24500418
  • Kool M, Jones DT, Jäger N, Northcott PA, Pugh TJ, Hovestadt V, Piro RM, Esparza LA, Markant SL, Remke M, Milde T, Bourdeaut F, Ryzhova M, Sturm D, Pfaff E, Stark S, Hutter S, Seker-Cin H, Johann P, Bender S, Schmidt C, Rausch T, Shih D, Reimand J, Sieber L, Wittmann A, Linke L, Witt H, Weber UD, Zapatka M, König R, Beroukhim R, Bergthold G, van Sluis P, Volckmann R, Koster J, Versteeg R, Schmidt S, Wolf S, Lawerenz C, Bartholomae CC, von Kalle C, Unterberg A, Herold-Mende C, Hofer S, Kulozik AE, von Deimling A, Scheurlen W, Felsberg J, Reifenberger G, Hasselblatt M, Crawford JR, Grant GA, Jabado N, Perry A, Cowdrey C, Croul S, Zadeh G, Korbel JO, Doz F, Delattre O, Bader GD, McCabe MG, Collins VP, Kieran MW, Cho YJ, Pomeroy SL, Witt O, Brors B, Taylor MD, Schüller U, Korshunov A, Eils R, Wechsler-Reya RJ, Lichter P, Pfister SM, .Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.Cancer Cell. 2014 Mar 17;25(3):393-405.
    24651015
  • Rork JF, Huang JT, Gordon LB, Kleinman M, Kieran MW, Liang MG.Initial cutaneous manifestations of Hutchinson-Gilford progeria syndrome.Pediatr Dermatol.;31(2):196-202.
    24456199
  • Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, Cheshier SH, Qi J, Liu KW, Wechsler-Reya R, Weiss WA, Swartling FJ, Kieran MW, Bradner JE, Beroukhim R, Cho YJ.BET bromodomain inhibition of MYC-amplified medulloblastoma.Clin Cancer Res. 2014 Feb 15;20(4):912-25.
    24297863
  • Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE.Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database.Pediatr Blood Cancer. 2014 Jan 30.
    24482038
  • Robison NJ, Campigotto F, Chi SN, Manley PE, Turner CD, Zimmerman MA, Chordas CA, Werger AM, Allen JC, Goldman S, Rubin JB, Isakoff MS, Pan WJ, Khatib ZA, Comito MA, Bendel AE, Pietrantonio JB, Kondrat L, Hubbs SM, Neuberg DS, Kieran MW.A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.Pediatr Blood Cancer. 2014 Apr;61(4):636-42.
    24123865
  • Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L, Sunkavalli A, Shillingford N, Calicchio ML, Lidov HG, Taha H, Martinez-Lage M, Santi M, Storm PB, Lee JY, Palmer JN, Adappa ND, Scott RM, Dunn IF, Laws ER, Stewart C, Ligon KL, Hoang MP, Van Hummelen P, Hahn WC, Louis DN, Resnick AC, Kieran MW, Getz G, Santagata S.Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.Nat Genet. 2014 Feb;46(2):161-5.
    24413733
  • Legault G, Kieran MW, Scott RM, Chordas C, Milla SS, Karajannis MA.Recurrent Ascites in a Patient With Low-grade Astrocytoma and Ventriculo-Peritoneal Shunt Treated With the Multikinase Inhibitor Sorafenib.J. Pediatr. Hematol. Oncol. 2013 Dec 17.
    24351969
  • Mammoto T, Jiang A, Jiang E, Panigrahy D, Kieran MW, Mammoto A.Role of collagen matrix in tumor angiogenesis and glioblastoma multiforme progression.Am J Pathol. 2013 Oct;183(4):1293-305.
    23928381
  • MacDonald TJ, Vezina G, Stewart CF, Turner D, Pierson CR, Chen L, Pollack IF, Gajjar A, Kieran MW.Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.Neuro Oncology. 2013 Oct;15(10):1438-44.
    24014381
  • Raabe E, Kieran MW, Cohen KJ.New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.Clin Cancer Res. 2013 Sep 1;19(17):4553-8.
    23881924
  • Panigrahy D, Kalish BT, Huang S, Bielenberg DR, Le HD, Yang J, Edin ML, Lee CR, Benny O, Mudge DK, Butterfield CE, Mammoto A, Mammoto T, Inceoglu B, Jenkins RL, Simpson MA, Akino T, Lih FB, Tomer KB, Ingber DE, Hammock BD, Falck JR, Manthati VL, Kaipainen A, D'Amore PA, Puder M, Zeldin DC, Kieran MW.Epoxyeicosanoids promote organ and tissue regeneration.Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13528-33.
    23898174
  • Dearling JL, Barnes JW, Panigrahy D, Zimmerman RE, Fahey F, Treves ST, Morrison MS, Kieran MW, Packard AB.Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.Nucl Med Biol. 2013 Aug;40(6):788-94.
    23701702
  • Ullrich NJ, Kieran MW, Miller DT, Gordon LB, Cho YJ, Silvera VM, Giobbie-Hurder A, Neuberg D, Kleinman ME.Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment.Neurology. 2013 Jul 30;81(5):427-30.
    23897869
  • Jones DT, Hutter B, Jäger N, Korshunov A, Kool M, Warnatz HJ, Zichner T, Lambert SR, Ryzhova M, Quang DA, Fontebasso AM, Stütz AM, Hutter S, Zuckermann M, Sturm D, Gronych J, Lasitschka B, Schmidt S, Seker-Cin H, Witt H, Sultan M, Ralser M, Northcott PA, Hovestadt V, Bender S, Pfaff E, Stark S, Faury D, Schwartzentruber J, Majewski J, Weber UD, Zapatka M, Raeder B, Schlesner M, Worth CL, Bartholomae CC, von Kalle C, Imbusch CD, Radomski S, Lawerenz C, van Sluis P, Koster J, Volckmann R, Versteeg R, Lehrach H, Monoranu C, Winkler B, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, Ebinger M, Schuhmann MU, Cho YJ, Pomeroy SL, von Deimling A, Witt O, Taylor MD, Wolf S, Karajannis MA, Eberhart CG, Scheurlen W, Hasselblatt M, Ligon KL, Kieran MW, Korbel JO, Yaspo ML, Brors B, Felsberg J, Reifenberger G, Collins VP, Jabado N, Eils R, Lichter P, Pfister SM, .Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma.Nat Genet. 2013 Aug;45(8):927-32.
    23817572
  • Kalish BT, Kieran MW, Puder M, Panigrahy D.The growing role of eicosanoids in tissue regeneration, repair, and wound healing.Prostaglandins & Other Lipid Mediators.;104-105:130-8.
    23727457
  • Ramkissoon LA, Horowitz PM, Craig JM, Ramkissoon SH, Rich BE, Schumacher SE, McKenna A, Lawrence MS, Bergthold G, Brastianos PK, Tabak B, Ducar MD, Van Hummelen P, MacConaill LE, Pouissant-Young T, Cho YJ, Taha H, Mahmoud M, Bowers DC, Margraf L, Tabori U, Hawkins C, Packer RJ, Hill DA, Pomeroy SL, Eberhart CG, Dunn IF, Goumnerova L, Getz G, Chan JA, Santagata S, Hahn WC, Stiles CD, Ligon AH, Kieran MW, Beroukhim R, Ligon KL.Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.Proc Natl Acad Sci U S A. 2013 May 14;110(20):8188-93.
    23633565
  • Robison NJ, Prabhu SP, Sun P, Chi SN, Kieran MW, Manley PE, Cohen LE, Goumnerova L, Smith ER, Scott RM, London WB, Ullrich NJ.Predictors of neoplastic disease in children with isolated pituitary stalk thickening.Pediatr Blood Cancer. 2013 May 14.
    23670879
  • Warren KE, Poussaint TY, Vezina G, Hargrave D, Packer RJ, Goldman S, Wen PY, Pollack IF, Zurakowski D, Kun LE, Prados MD, Rutkowski S, Kieran MW.Challenges With Defining Response to Antitumor Agents in Pediatric Neuro-Oncology: A Report From the Response Assessment in Pediatric Neuro-Oncology (RAPNO) Working Group.Pediatr Blood Cancer. 2013 Apr 26.
    23625747
  • Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, Stephen Lee KS, Wettersten HI, Ulu A, Hu X, Tam S, Hwang SH, Ingham ES, Kieran MW, Weiss RH, Ferrara KW, Hammock BD.Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis.Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6530-5.
    23553837
  • Janeway KA, Place AE, Kieran MW, Harris MH.Future of Clinical Genomics in Pediatric Oncology.J Clin Oncol. 2013 Apr 15.
    23589558
  • Blaney SM, Tagen M, Onar-Thomas A, Berg SL, Gururangan S, Scorsone K, Su J, Goldman S, Kieran MW, Kun L, Boyett J, Stewart C.A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.Pediatr Blood Cancer. 2013 Apr;60(4):627-32.
    23002039
  • Kieran MW, Kalluri R, Cho YJ.The VEGF pathway in cancer and disease: responses, resistance, and the path forward.Cold Spring Harb Perspect Med. 2012 Dec;2(12):a006593.
    23209176
  • Kieran MW, Roberts CW, Chi SN, Ligon KL, Rich BE, Macconaill LE, Garraway LA, Biegel JA.Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors.Pediatr Blood Cancer. 2012 Dec 15;59(7):1155-7.
    22997201
  • Heath JA, Zacharoulis S, Kieran MW.Pediatric neuro-oncology: current status and future directions.Asia Pac J Clin Oncol. 2012 Sep;8(3):223-31.
    22897924
  • Cleveland RH, Gordon LB, Kleinman ME, Miller DT, Gordon CM, Snyder BD, Nazarian A, Giobbie-Hurder A, Neuberg D, Kieran MW.A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome.Pediatr Radiol. 2012 Sep;42(9):1089-98.
    22752073
  • Craig JM, Vena N, Ramkissoon S, Idbaih A, Fouse SD, Ozek M, Sav A, Hill DA, Margraf LR, Eberhart CG, Kieran MW, Norden AD, Wen PY, Loda M, Santagata S, Ligon KL, Ligon AH.DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues.PLoS ONE. 2012;7(6):e38881.
    22719973
  • Manley PE, McKendrick K, McGillicudy M, Chi SN, Kieran MW, Cohen LE, Kothare S, Michael Scott R, Goumnerova LC, Sun P, London W, Marcus KJ, Pomeroy SL, Ullrich NJ.Sleep dysfunction in long term survivors of craniopharyngioma.J. Neurooncol. 2012 Jul;108(3):543-9.
    22528788
  • Rajagopal MU, Hathout Y, MacDonald TJ, Kieran MW, Gururangan S, Blaney SM, Phillips P, Packer R, Gordish-Dressman H, Rood BR.Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study.Proteomics. 2011 Mar;11(5):935-43.
    21271676
  • Chaponis D, Barnes JW, Dellagatta JL, Kesari S, Fast E, Sauvageot C, Panagrahy D, Greene ER, Ramakrishna N, Wen PY, Kung AL, Stiles C, Kieran MW.Lonafarnib (SCH66336) improves the activity of temozolomide and radiation for orthotopic malignant gliomas.J. Neurooncol. 2011 Jan 19.
    21246394
  • Prabhu SP, Ng S, Vajapeyam S, Kieran MW, Pollack IF, Geyer R, Haas-Kogan D, Boyett JM, Kun L, Poussaint TY.DTI assessment of the brainstem white matter tracts in pediatric BSG before and after therapy: a report from the Pediatric Brain Tumor Consortium.Child's Nervous System : Ch Ns : Official Journal Of The International Society For Pediatric Neurosurgery. 2011 Jan;27(1):11-8.
    21052693
  • Winkfield KM, Tsai HK, Yao X, Larson E, Neuberg D, Pomeroy SL, Ullrich NJ, Cohen LE, Kieran MW, Scott RM, Goumnerova LC, Marcus KJ.Long-term clinical outcomes following treatment of childhood craniopharyngioma.Pediatr Blood Cancer. 2010 Dec 1.
    21125615
  • Geyer JR, Stewart CF, Kocak M, Broniscer A, Phillips P, Douglas JG, Blaney SM, Packer RJ, Gururangan S, Banerjee A, Kieran MW, Kun LE, Gilbertson RJ, Boyett JM.A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas.Eur J Cancer. 2010 Dec;46(18):3287-93.
    20708924
  • Kieran MW, Walker D, Frappaz D, Prados M.Brain Tumors: From Childhood Through Adolescence Into Adulthood.J Clin Oncol. 2010 Nov 10;28(32):4783-9.
    20458039
  • Garcia I, Mayol G, Rodriguez E, Sunol M, Gershon TR, Rios J, Cheung NK, Kieran MW, George RE, Perez-Atayde AR, Casala C, Galvan P, de Torres C, Mora J, Lavarino C.Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma.Mol Cancer. 2010 Oct 15;9(1):277.
    20950435
  • Ullrich NJ, Zimmerman M, Smith E, Irons M, Marcus K, Kieran MW.Association of Rapidly Progressive Moyamoya Syndrome With Bevacizumab Treatment for Glioblastoma in a Child With Neurofibromatosis Type 1.J Child Neurol. 2010 Sep 7.
    20823033
  • Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, Quayle K, Goumnerova LC, Irons MB, Ullrich NJ.Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1.Pediatr Blood Cancer. 2010 Jul 1;54(7):890-6.
    20310005
  • Zacharoulis S, Chi S, Kadota R, Kieran M.Biological modification strategies following marrow ablative, high-dose chemotherapy (HDCT) with autologous hematopoietic stem cell rescue (AHSCR) for pediatric brain tumors.Pediatr Blood Cancer. 2010 Apr;54(4):654-6. Review.
    20146216
  • Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E, Tartaglia M, Schubbert S, Roberts AE, Gelb BD, Shannon K, Gutmann DH, McMahon M, Guerra C, Fagin JA, Yu B, Aoki Y, Neel BG, Balmain A, Drake RR, Nolan GP, Zenker M, Bollag G, Sebolt-Leopold J, Gibbs JB, Silva AJ, Patton EE, Viskochil DH, Kieran MW, Korf BR, Hagerman RJ, Packer RJ, Melese T.Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: From bedside to bench and back.Am J Med Genet A. 2010 Jan;152A(1):4-24.
    20014119
  • MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA.Profiling critical cancer gene mutations in clinical tumor samples.PLoS ONE. 2009;4(11):e7887.
    19924296
  • Ayyanar K, Blackman SC, Chordas C, Frazier L, Kieran MW.Metachronous mediastinal seminoma occurring after intracranial germinoma in an adolescent.J Pediatr Hematol Oncol. 2009 Nov;31(11):861-4.
    19779380
  • Herrington B,Kieran MW.Small molecule inhibitors in children with malignant gliomas.Pediatr Blood Cancer. 2009 Sep;53(3):312-7. Review.
    19434732
  • Turner CD,Chordas CA,Liptak CC,Rey-Casserly C,Delaney BL,Ullrich NJ,Goumnerova LC,Scott RM,Begley HC,Fletcher WJ,Yao X,Chi S,Kieran MW.Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only.Pediatr Blood Cancer. 2009 Sep;53(3):417-23.
    19479971
  • Manley P,Li X,Turner C,Chi S,Zimmerman MA,Chordas C,Gordon A,Baker A,Ullrich NJ,Goumnerova L,Marcus K,Hoffman K,Kieran MW.A prospective, blinded analysis of A-PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors.Pediatr Blood Cancer. 2009 Sep;53(3):343-7.
    19422022
  • Panigrahy D, Kaipainen A, Kieran MW, Huang S.PPARs: A Double-Edged Sword in Cancer Therapy?.PPAR Res. 2008;2008:350351.
    19590598
  • Samuel DP, Wen PY, Kieran MW.Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.Expert Opin Investig Drugs. 2009 Jul;18(7):973-83. Review.
    19548852
  • Chi SN,Zimmerman MA,Yao X,Cohen KJ,Burger P,Biegel JA,Rorke-Adams LB,Fisher MJ,Janss A,Mazewski C,Goldman S,Manley PE,Bowers DC,Bendel A,Rubin J,Turner CD,Marcus KJ,Goumnerova L,Ullrich NJ,Kieran MW.Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor.J Clin Oncol. 2009 Jan 20;27(3):385-9.
    19064966
  • Kieran MW,Supko JG,Wallace D,Fruscio R,Poussaint TY,Phillips P,Pollack I,Packer R,Boyett JM,Blaney S,Banerjee A,Geyer R,Friedman H,Goldman S,Kun LE,Macdonald T.Phase I study of SU5416, a small molecule inhibitor of the vascular endothelial growth factor receptor (VEGFR) in refractory pediatric central nervous system tumors.Pediatr Blood Cancer. 2009 Feb;52(2):169-76.
    19065567
  • Snuderl M,Chi SN,De Santis SM,Stemmer-Rachamimov AO,Betensky RA,De Girolami U,Kieran MW.Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas.J Neuropathol Exp Neurol. 2008 Sep;67(9):911-20.
    18716553
  • Sauvageot CM,Weatherbee JL,Kesari S,Winters SE,Barnes J,Dellagatta J,Ramakrishna NR,Stiles CD,Kung AL,Kieran MW,Wen PY.Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.Neuro-oncol. 2009 Apr;11(2):109-21.
    18682579
  • Kesari S, Schiff D, Henson JW, Muzikansky A, Gigas DC, Doherty L, Batchelor TT, Longtine JA, Ligon KL, Weaver S, Laforme A, Ramakrishna N, Black PM, Drappatz J, Ciampa A, Folkman J, Kieran M, Wen PY.Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults.Neuro-oncol. 2008 Jun;10(3):300-8.
    18403492
  • Gilheeney SW, Saad A, Chi S, Turner C, Ullrich NJ, Goumnerova L, Scott RM, Marcus K, Lehman L, De Girolami U, Kieran MW.Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy.J Neurooncol. 2008 Aug;89(1):89-95.
    18415046
  • Rauen KA, Hefner E, Carrillo K, Taylor J, Messier L, Aoki Y, Gripp KW, Matsubara Y, Proud VK, Hammond P, Allanson JE, Delrue MA, Axelrad ME, Lin AE, Doyle DA, Kerr B, Carey JC, McCormick F, Silva AJ, Kieran MW, Hinek A, Nguyen TT, Schoyer L.Molecular aspects, clinical aspects and possible treatment modalities for Costello syndrome: proceedings from the 1st International Costello Syndrome Research Symposium 2007.Am J Med Genet A. 2008 May 1;146(9):1205-17.
    18412122
  • Goumnerova L, Drzymalski D, Kieran M, Pomeroy S, Scott RM, Tarbell N.Long-term neurological and neurosurgical outcomes after surgery only in children with low-grade brain tumors.J Neurosurg Pediatrics. 2008 Apr;1(4):A354-5.
    18377286
  • Auriti C, Kieran MW, Deb G, Devito R, Pasquini L, Danhaive O.Remission of infantile generalized myofibromatosis after interferon alpha therapy.J Pediatr Hematol Oncol. 2008 Feb;30(2):179-81.
    18376275
  • Mundel TM, Yliniemi AM, Maeshima Y, Sugimoto H, Kieran M, Kalluri R.Type IV collagen alpha6 chain-derived noncollagenous domain 1 (alpha6(IV)NC1) inhibits angiogenesis and tumor growth.Int J Cancer. 2008 Apr 15;122(8):1738-44.
    18074349
  • MacDonald TJ, Stewart CF, Kocak M, Goldman S, Ellenbogen RG, Phillips P, Lafond D, Poussaint TY, Kieran MW, Boyett JM, Kun LE.Phase I clinical trial of cilengitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012.J Clin Oncol. 2008 Feb 20;26(6):919-24.
    18281665
  • Xie L, Palmsten K, Macdonald B, Kieran MW, Potenta S, Vong S, Kalluri R.Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth.Exp Biol Med (Maywood). 2008 Feb;233(2):155-62.
    18222970
  • Ziegler DS, Kung AL, Kieran MW.Anti-apoptosis mechanisms in malignant gliomas.J Clin Oncol. 2008 Jan 20;26(3):493-500. Review.
    18202424
  • Panigrahy D, Kaipainen A, Huang S, Butterfield CE, Barnes CM, Fannon M, Laforme AM, Chaponis DM, Folkman J, Kieran MW.PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.Proc Natl Acad Sci U S A. 2008 Jan 22;105(3):985-90.
    18199835
  • Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L.Brainstem lesions in neurofibromatosis type 1.Neurosurgery. 2007 Oct;61(4):762-6; discussion 766-7.
    17986937
  • Kieran MW,Gordon L,Kleinman M.New approaches to progeria.Pediatrics. 2007 Oct;120(4):834-41. Review.
    17908771
  • Gordon LB,McCarten KM,Giobbie-Hurder A,Machan JT,Campbell SE,Berns SD,Kieran MW.Disease progression in Hutchinson-Gilford progeria syndrome: impact on growth and development.Pediatrics. 2007 Oct;120(4):824-33.
    17908770
  • Kieran MW, Packer RJ, Onar A, Blaney SM, Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kirschmeier P, Statkevich P, Yver A, Boyett JM, Kun LE.Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Cons.J Clin Oncol. 2007 Jul 20;25(21):3137-43.
    17634493
  • Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.Neuro-oncol. 2007 Jul;9(3):354-63.
    17452651
  • Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL.Moyamoya following cranial irradiation for primary brain tumors in children.Neurology. 2007 Mar 20;68(12):932-8.
    17372129
  • Kaipainen A, Kieran MW, Huang S, Butterfield C, Bielenberg D, Mostoslavsky G, Mulligan R, Folkman J, Panigrahy D.PPARalpha Deficiency in Inflammatory Cells Suppresses Tumor Growth.PLoS ONE. 2007;2:e260.
    17327920
  • Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Wang Y, Hayes M, Murgo A, Weiner S, Boyett JM.Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report.Neuro-oncol. 2007 Apr;9(2):145-60.
    17293590
  • Sugimoto H, Mundel TM, Kieran MW, Kalluri R.Identification of fibroblast heterogeneity in the tumor microenvironment.Cancer Biol Ther. 2006 Dec;5(12):1640-6.
    17106243
  • Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW.Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.J Neurooncol. 2007 Mar;82(1):95-101.
    17031553
  • Sathornsumetee S, Hjelmeland AB, Keir ST, McLendon RE, Batt D, Ramsey T, Yusuff N, Rasheed BK, Kieran MW, Laforme A, Bigner DD, Friedman HS, Rich JN.AAL881, a Novel Small Molecule Inhibitor of RAF and Vascular Endothelial Growth Factor Receptor Activities, Blocks the Growth of Malignant Glioma.Cancer Res. 2006 Sep 1;66(17):8722-30.
    16951188
  • Cornetta K, Croop J, Dropcho E, Abonour R, Kieran MW, Kreissman S, Reeves L, Erickson LC, Williams DA.A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.Cancer Gene Ther. 2006 Sep;13(9):886-95.
    16645619
  • Ullrich NJ, Marcus K, Pomeroy SL, Turner CD, Zimmerman M, Lehmann LE, Scott RM, Goumnerova L, Gillan E, Kieran MW, Chi SN.Transverse Myelitis After Therapy For Primitive Neuroectodermal Tumors.Pediatr Neurol. 2006 Aug;35(2):122-125.
    16876009
  • Riedlinger WF, Juraszek AL, Jenkins KJ, Nugent AW, Balasubramanian S, Calicchio ML, Kieran MW, Collins T.Pulmonary vein stenosis: expression of receptor tyrosine kinases by lesional cells.Cardiovasc Pathol.;15(2):91-9.
    16533697
  • Waber DP, Pomeroy SL, Chiverton AM, Kieran MW, Scott RM, Goumnerova LC, Rivkin MJ.Everyday cognitive function after craniopharyngioma in childhood.Pediatr Neurol. 2006 Jan;34(1):13-9.
    16376272
  • Rich JN, Sathornsumetee S, Keir ST, Kieran MW, Laforme A, Kaipainen A, McLendon RE, Graner MW, Rasheed BK, Wang L, Reardon DA, Ryan AJ, Wheeler C, Dimery I, Bigner DD, Friedman HS.ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.Clin Cancer Res. 2005 Nov 15;11(22):8145-57.
    16299247
  • Kieran MW, Turner CD, Rubin JB, Chi SN, Zimmerman MA, Chordas C, Klement G, Laforme A, Gordon A, Thomas A, Neuberg D, Browder T, Folkman J.A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.J Pediatr Hematol Oncol. 2005 Nov;27(11):573-81.
    16282886
  • Prasad V, Fishman SJ, Mulliken JB, Fox VL, Liang MG, Klement G, Kieran MW, Burrows PE, Waltz DA, Powell J, Dubois J, Levy ML, Perez-Atayde AR, Kozakewich HP.Cutaneovisceral angiomatosis with thrombocytopenia.Pediatr Dev Pathol.;8(4):407-19.
    16034654
  • Kieran MW.Anti-angiogenic therapy in pediatric neuro-oncology.J Neurooncol. 2005 Dec;75(3):327-34.
    16195797
  • Panigrahy D, Huang S, Kieran MW, Kaipainen A.PPARgamma as a therapeutic target for tumor angiogenesis and metastasis.Cancer Biol Ther. 2005 Jul;4(7):687-93.
    16082179
  • Applebaum H, Kieran MW, Cripe TP, Coffin CM, Collins MH, Kaipainen A, Laforme A, Shamberger RC.The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study.J Pediatr Surg. 2005 Jun;40(6):999-1003; discussion 1003.
    15991185
  • Zacharoulis S, Kieran MW.Treatment of low-grade gliomas in children: an update.Expert Rev Neurother. 2004 Nov;4(6):1005-14.
    15853527
  • Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus K, Pomeroy SL, Turner CD, Chi SN, Chordas C, Kieran MW.Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.J Neurooncol. 2005 Mar;72(1):77-84.
    15803379
  • Sun Y, Mulkern RV, Schmidt K, Doshi S, Albert MS, Schmidt NO, Ziu M, Black P, Carrol R, Kieran MW.Quantification of water diffusion and relaxation times of human U87 tumors in a mouse model.NMR Biomed. 2004 Oct;17(6):399-404.
    15386627
  • Sun Y, Schmidt NO, Schmidt K, Doshi S, Rubin JB, Mulkern RV, Carroll R, Ziu M, Erkmen K, Poussaint TY, Black P, Albert M, Burstein D, Kieran MW.Perfusion MRI of U87 brain tumors in a mouse model.Magn Reson Med. 2004 May;51(5):893-9.
    15122670
  • Greene AK, Kieran M, Burrows PE, Mulliken JB, Kasser J, Fishman SJ.Wilms tumor screening is unnecessary in Klippel-Trenaunay syndrome.Pediatrics. 2004 Apr;113(4):e326-9.
    15060262
  • Kieran MW.Anti-angiogenic chemotherapy in central nervous system tumors.Cancer Treat Res. 2004;117:337-49.
    15015568
  • Hamano Y, Sugimoto H, Soubasakos MA, Kieran M, Olsen BR, Lawler J, Sudhakar A, Kalluri R.Thrombospondin-1 associated with tumor microenvironment contributes to low-dose cyclophosphamide-mediated endothelial cell apoptosis and tumor growth suppression.Cancer Res. 2004 Mar 1;64(5):1570-4.
    14996710
  • Gorlick R, Anderson P, Andrulis I, Arndt C, Beardsley GP, Bernstein M, Bridge J, Cheung NK, Dome JS, Ebb D, Gardner T, Gebhardt M, Grier H, Hansen M, Healey J, Helman L, Hock J, Houghton J, Houghton P, Huvos A, Khanna C, Kieran M, Kleinerman E, Ladanyi M, Lau C, Malkin D, Marina N, Meltzer P, Meyers P, Schofield D, Schwartz C, Smith MA, Toretsky J, Tsokos M, Wexler L, Wigginton J, Withrow S, Schoenfeldt M, Anderson B.Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.Clin Cancer Res. 2003 Nov 15;9(15):5442-53.
    14654523
  • Panigrahy D, Shen LQ, Kieran MW, Kaipainen A.Therapeutic potential of thiazolidinediones as anticancer agents.Expert Opin Investig Drugs. 2003 Dec;12(12):1925-37.
    14640937
  • Gesundheit B, Klement G, Senger C, Kerbel R, Kieran M, Baruchel S, Becker L.Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.Med Pediatr Oncol. 2003 Dec;41(6):516-26.
    14595708
  • Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, Kieran MW, Luster AD, Segal RA.A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8.
    14595012
  • Marcus KJ, Goumnerova L, Billett AL, Lavally B, Scott R, Bishop K, Xu R, Kieran M, Kooy H, Pomeroy SL, Tarbell NJ.Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2 Suppl):S196.
    12965450
  • Heath JA, Turner CD, Poussaint TY, Scott RM, Goumnerova L, Kieran MW.Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience.Pediatr Hematol Oncol. 2003 Oct-Nov;20(7):497-504.
    12959854
  • Kieran MW, Folkman J, Heymach J.Angiogenesis inhibitors and hypoxia.Nat Med. 2003 Sep;9(9):1104; author reply 1104-5.
    12949515
  • McLaughlin ME, Robson CD, Kieran MW, Jacks T, Pomeroy SL, Cameron S.Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation.J Pediatr Hematol Oncol. 2003 Aug;25(8):644-8.
    12902920
  • Carpentieri SC, Meyer EA, Delaney BL, Victoria ML, Gannon BK, Doyle JM, Kieran MW.Psychosocial and behavioral functioning among pediatric brain tumor survivors.J Neurooncol. 2003 Jul;63(3):279-87.
    12892234
  • Carpentieri SC, Waber DP, Pomeroy SL, Scott RM, Goumnerova LC, Kieran MW, Billett AL, Tarbell NJ.Neuropsychological functioning after surgery in children treated for brain tumor.Neurosurgery. 2003 Jun;52(6):1348-56; discussion 1356-.
    12762880
  • Marcus KJ, Dutton SC, Barnes P, Coleman CN, Pomeroy SL, Goumnerova L, Billett AL, Kieran M, Tarbell NJ.A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1182-5.
    12654425
  • Sugimoto H, Hamano Y, Charytan D, Cosgrove D, Kieran M, Sudhakar A, Kalluri R.Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria.J Biol Chem. 2003 Apr 11;278(15):12605-8.
    12538598
  • Browder T, Folkman J, Hahnfeldt P, Heymach J, Hlatky L, Kieran M, Rogers MS.Antiangiogenic therapy and p53.Science. 2002 Jul 26;297(5581):471; discussion 471.
    12143876
  • Carpentieri SC, Waber DP, Scott RM, Goumnerova LC, Kieran MW, Cohen LE, Kim F, Billett AL, Tarbell NJ, Pomeroy SL.Memory deficits among children with craniopharyngiomas.Neurosurgery. 2001 Nov;49(5):1053-7; discussion 1057-8.
    11846897
  • Meyer EA, Kieran MW.Psychological adjustment of 'surgery-only' pediatric neuro-oncology patients: a retrospective analysis.Psychooncology. 2002 Jan-Feb;11(1):74-9.
    11835594
  • Kieran MW, Billett A.Antiangiogenesis therapy. Current and future agents.Hematol Oncol Clin North Am. 2001 Oct;15(5):835-51, viii.
    11765376
  • Zissiadis Y, Dutton S, Kieran M, Goumnerova L, Scott RM, Kooy HM, Tarbell NJ.Stereotactic radiotherapy for pediatric intracranial germ cell tumors.Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):108-12.
    11516859
  • Packer RJ, Boyett JM, Janss AJ, Stavrou T, Kun L, Wisoff J, Russo C, Geyer R, Phillips P, Kieran M, Greenberg M, Goldman S, Hyder D, Heideman R, Jones-Wallace D, August GP, Smith SH, Moshang T.Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control.J Clin Oncol. 2001 Jan 15;19(2):480-7.
    11208842
  • Kieran MW.Advances in pediatric neuro-oncology.Curr Opin Neurol. 2000 Dec;13(6):627-34.
    11148661
  • Sadr IM, Tan PE, Kieran MW, Jenkins KJ.Mechanism of pulmonary vein stenosis in infants with normally connected veins.Am J Cardiol. 2000 Sep 1;86(5):577-9, A10.
    11009286
  • Kieran MW, Katz S, Vail B, Zon LI, Mayer BJ.Concentration-dependent positive and negative regulation of a MAP kinase by a MAP kinase kinase.Oncogene. 1999 Nov 18;18(48):6647-57.
    10597270
  • Rubin JB, Kieran MW.Innovative therapies for pediatric brain tumors.Curr Opin Pediatr. 1999 Feb;11(1):39-46.
    10084083
  • Kieran M, Blank V, Logeat F, Vandekerckhove J, Lottspeich F, Le Bail O, Urban MB, Kourilsky P, Baeuerle PA, Isral A.The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.Cell. 1990 Sep 7;62(5):1007-18.
    2203531